Mental Health DailyResearch. Evidence. Perspective.Published research on bupropion.
Lisdexamfetamine remains the only FDA-approved medication for binge-eating disorder — a serious condition affecting roughly 1.2% of adults. A 2026 human laboratory study by McKee and colleag…
Read articleIn the ever-evolving fight against tobacco addiction, the potential of antidepressants, particularly bupropion and nortriptyline, as smoking cessation aids has come into sharp focus. A compr…
Read articleMajor depressive disorder (MDD) is a significant global health concern, affecting over 280 million people worldwide. While numerous pharmacological options exist, challenges remain in achiev…
Read articleWellbutrin (Bupropion) is an antidepressant that is hypothesized to function as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is believed to predominantly increase levels of norepi…
Read articleWellbutrin (Bupropion) is considered an atypical antidepressant and smoking cessation aid that was first approved for medical use in 1989. It functions different than most antidepressants in…
Read articleNorepinephrine Dopamine Reuptake Inhibitors (NDRIs) are drugs that function by inhibiting the reuptake of the neurotransmitters norepinephrine and dopamine. This leads to increased neural co…
Read articleNorepinephrine Reuptake Inhibitors (NRIs) are drugs that function primarily by inhibiting the reuptake of the neurotransmitter norepinephrine (noradrenaline) and/or epinephrine (adrenaline).…
Read article
